Skip to main content
SpringerLink
Log in

Lactobacillus plantarum-derived metabolites sensitize the tumor-suppressive effects of butyrate by regulating the functional expression of SMCT1 in 5-FU-resistant colorectal cancer cells

  • Microbial Pathogenesis and Host-Microbe Interaction
  • Published:
Journal of Microbiology Aims and scope Submit manuscript

Abstract

A critical obstacle to the successful treatment of colorectal cancer (CRC) is chemoresistance. Chemoresistant CRC cells contribute to treatment failure by providing a mechanism of drug lethargy and modifying chemoresistance-associated molecules. The gut microbiota provide prophylactic and therapeutic effects by targeting CRC through anticancer mechanisms. Among them, Lactobacillus plantarum contributes to the health of the host and is clinically effective in treating CRC. This study confirmed that 5-fluorouracil (5-FU)-resistant CRC HCT116 (HCT116/5FUR) cells acquired butyrate-insensitive properties. To date, the relationship between 5-FU-resistant CRC and butyrate resistance has not been elucidated. Here, we demonstrated that the acquisition of butyrate resistance in HCT116/5FUR cells was strongly correlated with the inhibition of the expression and function of SMCT1, a major transporter of butyrate in colonocytes. L. plantarum-cultured cell-free supernatant (LP) restored the functional expression of SMCT1 in HCT116/5FUR cells, leading to butyrate-induced antiproliferative effect and apoptosis. These results suggest that LP has a synergistic effect on the SMCT1/butyrate-mediated tumor suppressor function and is a potential chemosensitizer to overcome dual 5-FU and butyrate resistance in HCT116 cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alfarouk, K.O., Verduzco, D., Rauch, C., Muddathir, A.K., Adil, H.H.B., Elhassan, G.O., Ibrahim, M.E., David Polo Orozco, J., Cardone, R.A., Reshkin, S.J., et al. 2014. Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question. Oncoscience 1, 777–802.

    Article  PubMed  PubMed Central  Google Scholar 

  • An, J. and Ha, E.M. 2016. Combination therapy of Lactobacillus plantarum supernatant and 5-fluouracil increases chemosensitivity in colorectal cancer cells. J. Microbiol. Biotechnol. 26, 1490–1503.

    Article  CAS  PubMed  Google Scholar 

  • An, J. and Ha, E.M. 2020. Lactobacillus-derived metabolites enhance the antitumor activity of 5-FU and inhibit metastatic behavior in 5-FU-resistant colorectal cancer cells by regulating claudin-1 expression. J. Microbiol. 58, 967–977.

    Article  CAS  PubMed  Google Scholar 

  • An, J., Seok, H., and Ha, E.M. 2021. GABA-producing Lactobacillus plantarum inhibits metastatic properties and induces apoptosis of 5-FU-resistant colorectal cancer cells via GABAB receptor signaling. J. Microbiol. 59, 202–216.

    Article  CAS  PubMed  Google Scholar 

  • Berdasco, M. and Esteller, M. 2010. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev. Cell. 19, 698–711.

    Article  CAS  PubMed  Google Scholar 

  • Berni Canani, R., Di Costanzo, M., and Leone, L. 2012. The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clin. Epigenet. 4, 4.

    Article  Google Scholar 

  • Bhutia, Y.D., Babu, E., Ramachandran, S., Yang, S., Thangaraju, M., and Ganapathy, V. 2016. SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms. Biochem. J. 473, 1113–1124.

    Article  CAS  PubMed  Google Scholar 

  • Bhutia, Y.D., Ogura, J., Sivaprakasam, S., and Ganapathy, V. 2017. Gut microbiome and colon cancer: role of bacterial metabolites and their molecular targets in the host. Curr. Colorectal Cancer Rep. 13, 111–118.

    Article  PubMed  PubMed Central  Google Scholar 

  • Borthakur, A., Anbazhagan, A.N., Kumar, A., Raheja, G., Singh, V., Ramaswamy, K., and Dudeja, P.K. 2010. The probiotic Lactobacillus plantarum counteracts TNF-α-induced downregulation of SMCT1 expression and function. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G928–G934.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Botta, C., Acquadro, A., Greppi, A., Barchi, L., Bertolino, M., Cocolin, L., and Rantsiou, K. 2017. Genomic assessment in Lactobacillus plantarum links the butyrogenic pathway with glutamine metabolism. Sci. Rep. 7, 15975.

    Article  PubMed  PubMed Central  Google Scholar 

  • Chang, C.Y. and Pan, T.M. 2019. Identification of bioactive compounds in Lactobacillus paracasei subsp. paracasei NTU 101-fer-mented reconstituted skimmed milk and their anti-cancer effect in combination with 5-fluorouracil on colorectal cancer cells. Food Funct. 10, 7634–7644.

    Article  CAS  PubMed  Google Scholar 

  • Choi, S.S., Kim, Y., Han, K.S., You, S., Oh, S., and Kim, S.H. 2006. Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro. Lett. Appl. Microbiol. 42, 452–458.

    Article  CAS  PubMed  Google Scholar 

  • Chou, T.C. 2006. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 58, 621–681.

    Article  CAS  PubMed  Google Scholar 

  • Chou, T.C. 2010. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 70, 440–446.

    Article  CAS  PubMed  Google Scholar 

  • Clausen, M.R., Bonnén, H., and Mortensen, P.B. 1991. Colonic fermentation of dietary fibre to short chain fatty acids in patients with adenomatous polyps and colonic cancer. Gut 32, 923–928.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cook, S.I. and Sellin, J.H. 1998. Review article: short chain fatty acids in health and disease. Aliment Pharmacol. Ther. 12, 499–507.

    Article  CAS  PubMed  Google Scholar 

  • Coothankandaswamy, V., Elangovan, S., Singh, N., Prasad, P.D., Thangaraju, M., and Ganapathy, V. 2013. The plasma membrane transporter SLC5A8 suppresses tumour progression through depletion of survivin without involving its transport function. Biochem. J. 450, 169–178.

    Article  CAS  PubMed  Google Scholar 

  • Davis, C.D. and Milner, J.A. 2009. Gastrointestinal microflora, food components and colon cancer prevention. J. Nutr. Biochem. 20, 743–752.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Donohoe, D.R., Collins, L.B., Wali, A., Bigler, R., Sun, W., and Bultman, S.J. 2012. The Warburg effect dictates the mechanism of buty-rate-mediated histone acetylation and cell proliferation. Mol. Cell 48, 612–626.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Donohoe, D.R., Curry, K.P., and Bultman, S.J. 2013. Microbial oncotarget: bacterial-produced butyrate, chemoprevention and Warburg effect. Oncotarget. 4, 182–183.

    Article  PubMed  PubMed Central  Google Scholar 

  • Eslami, M., Yousefi, B., Kokhaei, P., Hemati, M., Nejad, Z.R., Arabkari, V., and Namdar, A. 2019. Importance of probiotics in the prevention and treatment of colorectal cancer. J. Cell. Physiol. 234, 17127–17143.

    Article  CAS  PubMed  Google Scholar 

  • Ganapathy, V., Thangaraju, M., and Prasad, P.D. 2009. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol. Ther. 121, 29–40.

    Article  CAS  PubMed  Google Scholar 

  • Ganapathy, V., Thangaraju, M., Prasad, P.D., Martin, P.M., and Singh, N. 2013. Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr. Opin. Pharmacol. 13, 869–874.

    Article  CAS  PubMed  Google Scholar 

  • Gaschott, T. and Stein, J. 2003. Short-chain fatty acids and colon cancer cells: the vitamin D receptor-butyrate connection. Recent Results Cancer Res. 164, 247–257.

    Article  CAS  PubMed  Google Scholar 

  • Gillet, J.P. and Gottesman, M.M. 2010. Mechanisms of multidrug resistance in cancer. Methods Mol. Biol. 596, 47–76.

    Article  CAS  PubMed  Google Scholar 

  • Gonçalves, P., Araújo, J.R., Pinho, M.J., and Martel, F. 2011. In vitro studies on the inhibition of colon cancer by butyrate and polyphenolic compounds. Nutr. Cancer 63, 282–294.

    Article  PubMed  Google Scholar 

  • Gonçalves, P. and Martel, F. 2013. Butyrate and colorectal cancer: the role of butyrate transport. Curr. Drug Metab. 14, 994–1008.

    Article  PubMed  Google Scholar 

  • Greenhalgh, K., Meyer, K.M., Aagaard, K.M., and Wilmes, P. 2016. The human gut microbiome in health: establishment and resilience of microbiota over a lifetime. Environ. Microbiol. 18, 2103–2116.

    Article  PubMed  PubMed Central  Google Scholar 

  • Guilloteau, P., Martin, L., Eeckhaut, V., Ducatelle, R., Zabielski, R., and Van Immerseel, F. 2010. From the gut to the peripheral tissues: the multiple effects of butyrate. Nutr. Res. Rev. 23, 366–384.

    Article  CAS  PubMed  Google Scholar 

  • Gupta, N., Martin, P.M., Prasad, P.D., and Ganapathy, V. 2006. SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter. Life Sci. 78, 2419–2425.

    Article  CAS  PubMed  Google Scholar 

  • Hadjiagapiou, C., Schmidt, L., Dudeja, P.K., Layden, T.J., and Ramaswamy, K. 2000. Mechanism(s) of butyrate transport in Caco-2 cells: role of monocarboxylate transporter 1. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G775–G780.

    Article  CAS  PubMed  Google Scholar 

  • Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J., and Brummer, R.J. 2008. Review article: the role of butyrate on colonic function. Aliment Pharmacol. Ther. 27, 104–119.

    Article  CAS  PubMed  Google Scholar 

  • Hanahan, D. and Weinberg, R.A. 2011. Hallmarks of cancer: the next generation. Cell 144, 646–674.

    Article  CAS  PubMed  Google Scholar 

  • Hemarajata, P. and Versalovic, J. 2013. Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap. Adv. Gastroenterol. 6, 39–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ho, A.S., Turcan, S., and Chan, T.A. 2013. Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management. Onco. Targets Ther. 6, 223–232.

    PubMed  PubMed Central  Google Scholar 

  • Hu, B.S., Xiong, S.M., Li, G., and Li, J.P. 2016. Downregulation of SLC5A8 inhibits hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling. Tumour Biol. 37, 13445–13453.

    Article  CAS  PubMed  Google Scholar 

  • Jones, P.A. and Baylin, S.B. 2007. The epigenomics of cancer. Cell 128, 683–692.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kameue, C., Tsukahara, T., Yamada, K., Koyama, H., Iwasaki, Y., Nakayama, K., and Ushida, K. 2004. Dietary sodium gluconate protects rats from large bowel cancer by stimulating butyrate production. J. Nutr. 134, 940–944.

    Article  CAS  PubMed  Google Scholar 

  • Kanazawa, Y., Yamada, T., Fujita, I., Kakinuma, D., Matsuno, K., Arai, H., Shimoda, T., Ko, K., Kato, S., Matsutani, T., et al. 2017. In vitro chemosensitivity test for gastric cancer specimens predicts effectiveness of oxaliplatin and 5-fluorouracil. Anticancer Res. 37, 6401–6405.

    CAS  PubMed  Google Scholar 

  • Kang, H.R., Choi, H.G., Jeon, C.K., Lim, S.J., and Kim, S.H. 2016. Butyrate-mediated acquisition of chemoresistance by human colon cancer cells. Oncol. Rep. 36, 1119–1126.

    Article  CAS  PubMed  Google Scholar 

  • Kerr, C.A., Dunne, R., Hines, B.M., Zucker, M., Cosgrove, L., Ruszkiewicz, A., Lockett, T., and Head, R. 2009. Measuring the combinatorial expression of solute transporters and metalloproteinases transcripts in colorectal cancer. BMC Res. Notes 2, 164.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kim, J.W. and Dang, C.V. 2006. Cancer’s molecular sweet tooth and the Warburg effect. Cancer Res. 66, 8927–8930.

    Article  CAS  PubMed  Google Scholar 

  • Kim, H., Kim, H.S., Park, W.J., and Chung, D.K. 2015. Inhibitory effect of Lactobacillus plantarum extracts on HT-29 colon cancer cell apoptosis induced by Staphylococcus aureus and its alpha-toxin. J. Microbiol. Biotechnol. 25, 1849–1855.

    Article  CAS  PubMed  Google Scholar 

  • Kroemer, G. and Pouyssegur, J. 2008. Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell 13, 472–482.

    Article  CAS  PubMed  Google Scholar 

  • Kuhn, K.A. and Stappenbeck, T.S. 2013. Peripheral education of the immune system by the colonic microbiota. Semin. Immunol. 25, 364–369.

    Article  CAS  PubMed  Google Scholar 

  • Kumar, A., Alrefai, W.A., Borthakur, A., and Dudeja, P.K. 2015. Lactobacillus acidophilus counteracts enteropathogenic E. coli-induced inhibition of butyrate uptake in intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 309, G602–G607.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Latchman, J., Guastella, A., and Tofthagen, C. 2014. 5-Fluorouracil toxicity and dihydropyrimidine dehydrogenase enzyme: implications for practice. Clin. J. Oncol. Nurs. 18, 581–585.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lazarova, D.L. and Bordonaro, M. 2016. Vimentin, colon cancer progression and resistance to butyrate and other HDACis. J. Cell Mol. Med. 20, 989–993.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee, S.M., Kim, N., Nam, R.H., Park, J.H., Choi, S.I., Park, Y.T., Kim, Y.R., Seok, Y.J., Shin, C.M., and Lee, D.H. 2019. Gut microbiota and butyrate level changes associated with the long-term administration of proton pump inhibitors to old rats. Sci. Rep. 9, 6626.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lee, B.H., Yegnasubramanian, S., Lin, X., and Nelson, W.G. 2005. Procainamide is a specific inhibitor of DNA methyltransferase 1. J. Biol. Chem. 280, 40749–40756.

    Article  CAS  PubMed  Google Scholar 

  • Li, H., Myeroff, L., Smiraglia, D., Romero, M.F., Pretlow, T.P., Kasturi, L., Lutterbaugh, J., Rerko, R.M., Casey, G., Issa, J.P., et al. 2003. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc. Natl. Acad. Sci. USA 100, 8412–8417.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • López de Silanes, I., Olmo, N., Turnay, J., González de Buitrago, G., Pérez-Ramos, P., Guzman-Aranguez, A., Garcia-Díez, M., Lecona, E., Gorospe, M., and Lizarbe, M.A. 2004. Acquisition of resistance to butyrate enhances survival after stress and induces malignancy of human colon carcinoma cells. Cancer Res. 64, 4593–4600.

    Article  PubMed  Google Scholar 

  • Lupton, J.R. 2004. Microbial degradation products influence colon cancer risk: the butyrate controversy. J. Nutr. 134, 479–482.

    Article  CAS  PubMed  Google Scholar 

  • Marks, P., Rifkind, R.A., Richon, V.M., Breslow, R., Miller, T., and Kelly, W.K. 2001. Histone deacetylases and cancer: causes and therapies. Nat. Rev. Cancer 1, 194–202.

    Article  CAS  PubMed  Google Scholar 

  • Mazzoli, R. and Pessione, E. 2016. The neuro-endocrinological role of microbial glutamate and GABA signaling. Front. Microbiol. 7, 1934.

    Article  PubMed  PubMed Central  Google Scholar 

  • McIntyre, A., Gibson, P.R., and Young, G.P. 1993. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34, 386–391.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Medina, V., Afonso, J.J., Alvarez-Arguelles, H., Hernández, C., and González, F. 1998. Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine-induced rat colon cancer. JPEN J. Parenter. Enteral Nutr. 22, 14–17.

    Article  CAS  PubMed  Google Scholar 

  • Mehnert, J.M. and Kelly, W.K. 2007. Histone deacetylase inhibitors: biology and mechanism of action. Cancer J. 13, 23–29.

    Article  CAS  PubMed  Google Scholar 

  • Miller, K.D., Nogueira, L., Mariotto, A.B., Rowland, J.H., Yabroff, K.R., Alfano, C.M., Jemal, A., Kramer, J.L., and Siegel, R.L. 2019. Cancer treatment and survivorship statistics, 2019. CA Cancer J. Clin. 69, 363–385.

    Article  PubMed  Google Scholar 

  • Miyauchi, S., Gopal, E., Fei, Y.J., and Ganapathy, V. 2004. Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na+-coupled transporter for short-chain fatty acids. J. Biol. Chem. 279, 13293–13296.

    Article  CAS  PubMed  Google Scholar 

  • Monneret, C. 2005. Histone deacetylase inhibitors. Eur. J. Med. Chem. 40, 1–13.

    Article  CAS  PubMed  Google Scholar 

  • Montagnani, F., Chiriatti, A., Turrisi, G., Francini, G., and Fiorentini, G. 2011. A systematic review of FOLFOXIRI chemotherapy for the first-line treatment of metastatic colorectal cancer: improved efficacy at the cost of increased toxicity. Colorectal Dis. 13, 846–852.

    Article  CAS  PubMed  Google Scholar 

  • Mooij, M.G., Nies, A.T., Knibbe, C.A., Schaeffeler, E., Tibboel, D., Schwab, M., and de Wildt, S.N. 2016. Development of human membrane transporters: drug disposition and pharmacogenetics. Clin. Pharmacokinet. 55, 507–524.

    Article  CAS  PubMed  Google Scholar 

  • Nicholson, J.K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., and Pettersson, S. 2012. Host-gut microbiota metabolic interactions. Science 336, 1262–1267.

    Article  CAS  PubMed  Google Scholar 

  • O’Dwyer, P.J., Eckhardt, S.G., Haller, D.G., Tepper, J., Ahnen, D., Hamilton, S., Benson, A.B.3rd, Rothenberg, M., Petrelli, N., Lenz, H.J., et al. 2007. Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups. J. Clin. Oncol. 25, 2313–2321.

    Article  PubMed  Google Scholar 

  • Orlando, A., Messa, C., Linsalata, M., Cavallini, A., and Russo, F. 2009. Effects of Lactobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines. Immunopharmacol. Immunotoxicol. 31, 108–116.

    Article  CAS  PubMed  Google Scholar 

  • Pan, X., Yang, Y., and Zhang, J.R. 2014. Molecular basis of host specificity in human pathogenic bacteria. Emerg. Microbes Infect. 3, e23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Paolillo, R., Romano Carratelli, C., Sorrentino, S., Mazzola, N., and Rizzo, A. 2009. Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells. Int. Immunopharmacol. 9, 1265–1271.

    Article  CAS  PubMed  Google Scholar 

  • Papanastasopoulos, P. and Stebbing, J. 2014. Molecular basis of 5-fluorouracil-related toxicity: lessons from clinical practice. Anti-cancer Res. 34, 1531–1535.

    CAS  Google Scholar 

  • Paroder, V., Spencer, S.R., Paroder, M., Arango, D., Schwartz, S. Jr., Mariadason, J.M., Augenlicht, L.H., Eskandari, S., and Carrasco, N. 2006. Na+/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT. Proc. Natl. Acad. Sci. USA 103, 7270–7275.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rawla, P., Sunkara, T., and Barsouk, A. 2019. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz. Gastroenterol. 14, 89–103.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Schroeder, B.O. and Bäckhed, F. 2016. Signals from the gut microbiota to distant organs in physiology and disease. Nat. Med. 22, 1079–1089.

    Article  CAS  PubMed  Google Scholar 

  • Serpa, J., Caiado, F., Carvalho, T., Torre, C., Gonçalves, L.G., Casalou, C., Lamosa, P., Rodrigues, M., Zhu, Z., Lam, E.W., et al. 2010. Butyrate-rich colonic microenvironment is a relevant selection factor for metabolically adapted tumor cells. J. Biol. Chem. 285, 39211–39223.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sharma, M. and Shukla, G. 2016. Metabiotics: one step ahead of probiotics; an insight into mechanisms involved in anticancerous effect in colorectal cancer. Front. Microbiol. 7, 1940.

    Article  PubMed  PubMed Central  Google Scholar 

  • Shenderov, B.A. 2013. Metabiotics: novel idea or natural development of probiotic conception. Microb. Ecol. Health Dis. 24, 20399.

    Google Scholar 

  • Siddiqui, K.M. and Chopra, D.P. 1984. Primary and long term epithelial cell cultures from human fetal normal colonic mucosa. In Vitro 20, 859–868.

    Article  CAS  PubMed  Google Scholar 

  • Sonveaux, P., Végran, F., Schroeder, T., Wergin, M.C., Verrax, J., Rabbani, Z.N., De Saedeleer, C.J., Kennedy, K.M., Diepart, C., Jordan, B.F., et al. 2008. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J. Clin. Invest. 118, 3930–3942.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Thangaraju, M., Cresci, G., Itagaki, S., Mellinger, J., Browning, D.D., Berger, F.G., Prasad, P.D., and Ganapathy, V. 2008. Sodium-coupled transport of the short chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer. J. Gastrointest. Surg. 12, 1773–1781.

    Article  PubMed  Google Scholar 

  • Thomas, H. and Coley, H.M. 2003. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting P-glycoprotein. Cancer Control 10, 159–165.

    Article  PubMed  Google Scholar 

  • Troost, F.J., van Baarlen, P., Lindsey, P., Kodde, A., de Vos, W.M., Kleerebezem, M., and Brummer, R.J. 2008. Identification of the transcriptional response of human intestinal mucosa to Lactobacillus plantarum WCFS1 in vivo. BMC Genomics 9, 374.

    Article  PubMed  PubMed Central  Google Scholar 

  • Vander Heiden, M.G., Cantley, L.C., and Thompson, C.B. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029–1033.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wei, L., Chen, J., Wen, J., Wu, D., Ma, X., Chen, Z., and Huang, J. 2020. Efficacy of oxaliplatin/5-fluorouracil/capecitabine-cetux-imab combination therapy and its effects on K-Ras mutations in advanced colorectal cancer. Med. Sci. Monit. 26, e919031.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Whitman, S.P., Hackanson, B., Liyanarachchi, S., Liu, S., Rush, L.J., Maharry, K., Margeson, D., Davuluri, R., Wen, J., Witte, T., et al. 2008. DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication. Blood 112, 2013–2016.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yue, Y.C., Yang, B.Y., Lu, J., Zhang, S.W., Liu, L., Nassar, K., Xu, X.X., Pang, X.Y., and Lv, J.P. 2020a. Metabolite secretions of Lactobacillus plantarum YYC-3 may inhibit colon cancer cell metastasis by suppressing the VEGF-MMP2/9 signaling pathway. Microb. Cell Fact. 19, 213.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yue, Y.C., Ye, K., Lu, J., Wang, X., Zhang, S.W., Liu, L., Yang, B., Nassar, K., Xu, X.X., Pang, X.Y., et al. 2020b. Probiotic strain Lactobacillus plantarum YYC-3 prevents colon cancer in mice by regulating the tumour microenvironment. Biomed. Pharmacother. 127, 110159.

    Article  CAS  PubMed  Google Scholar 

  • Zeng, H., Taussig, D.P., Cheng, W.H., Johnson, L.K., and Hakkak, R. 2017. Butyrate inhibits cancerous HCT116 colon cell proliferation but to a lesser extent in noncancerous NCM460 colon cells. Nutrients 9, 25.

    Article  PubMed Central  Google Scholar 

  • Zheng, H.C. 2017. The molecular mechanisms of chemoresistance in cancers. Oncotarget. 8, 59950–59964.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This research was funded by the National Research Foundation of Korea (NRF-2016R1D1A1B03934262).

Author information

Author notes

  1. These authors contributed equally to this work.

Authors and Affiliations

  1. College of Pharmacy, Daegu Catholic University, Gyeongsan, 38430, Republic of Korea

    Hye-Ju Kim & Eun-Mi Ha

  2. Medical Convergence Textile Center, Gyeongbuk Techno Park, Gyeongsan, 38408, Republic of Korea

    JaeJin An

Authors
  1. Hye-Ju Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. JaeJin An
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eun-Mi Ha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eun-Mi Ha.

Additional information

Conflict of Interest

The authors have no conflict of interest to report.

Supplemental material for this article may be found at http://www.springerlink.com/content/120956.

Electronic Supplementary Material

12275_2022_1533_MOESM1_ESM.pdf

Lactobacillus plantarum-derived metabolites sensitize the tumor-suppressive effects of butyrate by regulating the functional expression of SMCT1 in 5-FU-resistant colorectal cancer cells

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, HJ., An, J. & Ha, EM. Lactobacillus plantarum-derived metabolites sensitize the tumor-suppressive effects of butyrate by regulating the functional expression of SMCT1 in 5-FU-resistant colorectal cancer cells. J Microbiol. 60, 100–117 (2022). https://doi.org/10.1007/s12275-022-1533-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12275-022-1533-1

Keywords

Search

Navigation